Data from Cervical Cytology History Form: Type Collected [CRF 13, question 4] Study Description A Phase II, open-label, multi-center study that evaluated the immunogenicity, safety, tolerability, and
Data shown are median values (interquartile range) unless otherwise indicated. * At time of sampling § HLA-B*27, B51, B*5701/03, B*5801 and B*8101 Characteristics of HVTN 502 and 503 trial participant
Data from Laboratory Results Form: HIV Test Details [CRF 5] Study Description A randomized, single-blinded trial evaluating two licensed vaccine products, Recombivax and Twinrix, given in a two-dose s
This purpose of the study is to assess the safety and immunogenicity of a GSK Biologicals' candidate tuberculosis vaccine (692342) when administered concomitantly with or after the Expanded Programme